1007307-94-9

Upstream product

• 1007308-63-5 4-(3-chloro-4-methoxy-benzylamino)-6-amino-7-methoxy-8-propyl-quinazoline 
• 79-04-9 chloroacetyl chloride 
• 53449-14-2 7-chloro-6-nitro-4(3H)-quinazolinone 
• 162012-71-7 4,7-dichloro-6-nitro-quinazoline 
• 1007308-59-9 C₁₆H₁₂Cl₂N₄O₃ 
• 1007308-97-5 (3-chloro-4-methoxy-benzyl)-(7-fluoro-6-nitro-quinazolin-4-yl)-amine 
• 1007308-60-2 N₄-(3-chloro-4-methoxy-benzyl)-(7-methoxy-6-nitro-quinazolin-4-yl)-amine 
• 1007308-61-3 4-(3-chloro-4-methoxy-benzylamino)-6-nitro-quinazolin-7-ol 
• 1007307-67-6 8-allyl-4-(3-chloro-4-methoxy-benzylamino)-6-nitro-quinazolin-7-ol 
• 1007307-68-7 (8-allyl-7-methoxy-6-nitro-quinazolin-4-yl)-(3-chloro-4-methoxy-benzyl)-amine 
• 1007308-62-4 C₁₉H₁₇ClN₄O₄ 

Relevant academic research and scientific papers

QUINAZOLINE DERIVATIVE AS PHOSPHODIESTERASE INHIBITOR AND A PROCESS FOR PREPARING THE SAME

The present invention relates to a quinazoline derivative, a preparation method thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, a hydrate thereof, a pharmaceutical composition comprising the same and use thereof as a therapeutic agent. The present inveniont relates to a quinazoline derivative exhibiting inhibitory activity against C